Fulton Jeang has a legal team focused on FemTech, a category of software, diagnostics, products, and services that apply technical solutions to address unique issues related to women's health, because we perceive the large gap in women's healthcare that is unmet by traditional medical, pharma, and healthcare companies. We are not alone in this perception. It is projected that the FemTech market size, valued at USD 35.5 billion in 2023, is estimated to grow at 16% CAGR to 139.5 billion in 2032.

​

Our multidisciplinary legal team is well-positioned to serve the FemTech industry with a comprehensive suite of services across various critical practice areas in a cost-effective manner. We offer extensive expertise in corporate law, patent (biotech, genetics, pharma, medical devices, machine learning, AI-assisted predictive modeling, etc.), trademark, copyright, biomedical science & medicine, employment law, mergers and acquisitions (M&A), securities, tax strategies, and data privacy regulations. With the rapid growth of the FemTech sector, companies face unique challenges in navigating innovation, protecting their intellectual property, ensuring compliance with health-related data privacy standards (such as HIPAA), and securing funding. Our multidisciplinary team is dedicated to guiding FemTech businesses through every phase of their lifecycle, from startup formation and patenting groundbreaking technologies to mergers and acquisitions and ensuring compliance with a changing regulatory landscape. We understand the nuances of this evolving field and are committed to helping FemTech companies thrive in a competitive market.

​

Fulton Jeang PLLC is a certified women-owned (WBE & WOSB) and Historically Underutilized Business (HUB) law firm. We have garnered a spot among IP law firms recognized by Chambers USA in its Regional Spotlight for Texas.